We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NIH to Study Remdesivir-Like Compound for COVID-19
The item has been added to your shopping cart.
NIH to Study Remdesivir-Like Compound for COVID-19
The National Institutes of Health (NIH) said it plans to study an investigational antiviral from Gilead Sciences that proponents believe may offer significant advantages over remdesivir as a possible COVID-19 treatment.